Read and Download eBook Full
Author: Joseph Wouk
Publisher: Lulu.com
Published: 2009-03-01
Total Pages: 269
ISBN-13: 0578004399
DOWNLOAD EBOOKTold with humor and honesty, Wouk pulls the reader through his thought processes as he watches his mind dissolve from the subcortical dementia caused by his particular variety of MS.
Author: Gary W. Jay
Publisher: CRC Press
Published: 2007-06-20
Total Pages: 304
ISBN-13: 1420004557
DOWNLOAD EBOOKProviding a general approach to the understanding and management of all forms of chronic pain, this book offers a clear and reader-friendly format that clarifies procedures in the diagnosis, assessment, and treatment of the most common chronic non-cancer pain entities. Describing various types of intractable non-cancer pain, including neuropathic
Author: Elaine A. Moore
Publisher: McFarland
Published: 2009-01-22
Total Pages: 224
ISBN-13: 0786452587
DOWNLOAD EBOOKNaltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.
Author: Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation
Publisher: National Academies Press
Published: 2006-03-23
Total Pages: 422
ISBN-13: 0309133343
DOWNLOAD EBOOKThis book is the seventh in a series of titles from the National Research Council that addresses the effects of exposure to low dose LET (Linear Energy Transfer) ionizing radiation and human health. Updating information previously presented in the 1990 publication, Health Effects of Exposure to Low Levels of Ionizing Radiation: BEIR V, this book draws upon new data in both epidemiologic and experimental research. Ionizing radiation arises from both natural and man-made sources and at very high doses can produce damaging effects in human tissue that can be evident within days after exposure. However, it is the low-dose exposures that are the focus of this book. So-called “late” effects, such as cancer, are produced many years after the initial exposure. This book is among the first of its kind to include detailed risk estimates for cancer incidence in addition to cancer mortality. BEIR VII offers a full review of the available biological, biophysical, and epidemiological literature since the last BEIR report on the subject and develops the most up-to-date and comprehensive risk estimates for cancer and other health effects from exposure to low-level ionizing radiation.
Author: Robert Rodgers, PhD
Publisher: Parkinsons Recovery
Published: 2014-02-10
Total Pages: 29
ISBN-13:
DOWNLOAD EBOOKLDN (Low Dose Naltrexone) is a proven-safe (by the FDA in 50mg doses!) off-label prescription drug which has gained a great deal of attention over the past few months due to its remarkable disease modifying effects of controlling and reversing symptoms of Parkinson's Disease. Lexie is one person who has experienced a reversal of most of her Parkinsons Disease symptoms over the past 5 years. She was officially diagnosed with Parkinsons disease in 2008 (although her non-motor symptoms began 20 years earlier). In this question and answer format with Robert Rodgers, PhD from Parkinsons Recovery, Lexie offers detailed information about her experience with taking LDN. She has been able to titrate off her daily use of traditional PD medications, while controlling and reversing most of her own PD symptoms, thanks to LDN. Many doctors are not familiar with LDN as a treatment for Parkinson's symptoms. It is a prescription medication, so a prescription from a doctor is necessary. Lexie offers suggestions about how to discuss a request for a LDN prescription from your doctor and offers specific suggestions about where to get LDN once a prescription is in hand. This interview was originally published in Pioneers of Recovery, a series of stories by people who succeeded in reversing their Parkinson's symptoms using one modality or another. Lexie's story of recovery centers on the use of LDN which has been so beneficial to her own recovery from Parkinsons Disease.
Author: Diana Barbara Dutton
Publisher: Cambridge University Press
Published: 1992-05-29
Total Pages: 548
ISBN-13: 9780521395571
DOWNLOAD EBOOKThe distance between medical and public priorities is exposed in four case studies that reveal the human choices governing scientific innnovation and explore the political, economic and social factors influencing those choices.
Author: Jeffrey A. Cohen
Publisher: Cambridge University Press
Published: 2011-10-20
Total Pages: 771
ISBN-13: 1139502379
DOWNLOAD EBOOKThis book comprehensively reviews the current state of clinical trial methods in multiple sclerosis treatment, providing investigators, sponsors and specialists with current knowledge of outcome measures and study designs for disease and symptom management. The status of the rapidly evolving field of disease-modifying drugs is presented, with emphasis on the most promising therapies currently being tested. Experts discuss disease and symptom management for MS subtypes, including neuromyelitis optica and pediatric MS. In addition, key scientific advances in MS pathology, genetics, immunology and epidemiology are presented. The fourth edition has been extensively revised, featuring more than 50% new material. All chapters have been substantially updated to provide current information on rapidly evolving topics and this volume contains 15 new chapters, reflecting the growth of the field in recent years. This book is an essential reference for practitioners caring for MS patients, investigators planning or conducting clinical trials, and clinical trial sponsors.
Author: Mary Boyle Bradley
Publisher:
Published: 2009
Total Pages: 0
ISBN-13: 9781432711504
DOWNLOAD EBOOK"In 1986, when I first discovered LDN, if I had Mary Boyle Bradley on my team, this drug would have been approved, marketed and manufactured by a reputable pharmaceutical company. I have no doubt about that." Dr. Bernard Bihari The story is simple. It is about love, life and hope. After years of battling with the onslaught of her husband's Primary Progressive Multiple Sclerosis, Mary stumbled on a little known doctor in New York City, Dr. Bernard Bihari. Many people on the internet claimed that Dr. Bihari knew how to stop every type of MS from progressing. Even better, it was claimed that he could help everyone with an autoimmune disorder, ranging from psoriasis to AIDS. It was claimed that Dr. Bihari could help them with Low Dose Naltrexone (LDN). Eventually, Mary's husband took a leap of faith and put Dr. Bihari's work to the test. LDN worked. It stopped his MS from progressing. Since September 2002, a worldwide campaign has ignited with passionate momentum to get LDN medically recognized as a treatment for MS and all autoimmune disorders. LDN is a cheap, generic, out of patent drug with no known side-effects. Despite the fact that there is no financial incentive to entice any pharmaceutical company to investigate new uses for Naltrexone, the ambition is for LDN to hit the masses and improve the lives of millions. Small scale LDN clinical trials are finally making progress across the globe and are paving the way for a much better future for everyone who suffers from an autoimmune disorder.
Author: Julia Schopick
Publisher:
Published: 2018-10-15
Total Pages:
ISBN-13: 9780982969038
DOWNLOAD EBOOKThis book is about Low Dose Natlrexone, a low-cost treatment for autoimmune diseases such Crohn's, Fibromyalgia, Chronic Fatigue Syndrome, Rheumatoid Arthritis, MS, Lupus, etc. There are patient contributions from the US, UK and Europe
Author: Robert E. Bunyard
Publisher:
Published: 2021-06-28
Total Pages: 22
ISBN-13: 9781638440659
DOWNLOAD EBOOKChemical dependency and its denial aspects are the heart and soul of one of, if not the greatest, horrific problems in our society, yesterday, today and probably many tomorrows to come! How do we deal with it? Well, the most popular world known strategies would be through the following: AA (Alcoholics Anonymous) NA (Narcotics Anonymous) And even GA (Gambling Anonymous) The disease is incurable but arrestable using the aforementioned twelve-step programs. Well, guess what? After entering an advanced substance drug rehab program in the fall of 1985, I began to slowly realize and learn a better way (especially from a neurological standpoint) to get back on track (so to speak) and even formulated a Super 7-Step Program that works even better! I got it copyrighted through Washington, DC, and you really do need to read it and take it to heart. I won't say all, but most MDs don't even know this!
